---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "mC7k44PGPA5lABHYB50FXf9pPKUupoDH8Plza0Hvb8QRLiTUcGJvwMhLw3c6ER01heuaAE25kSQV7hckeS5d25+vzWDoA6ZeKuMd6W8L0ECV8SGHKkzu7AM6tOer6XWv4VKWNIUdvrrBYXOcqw+23+IQOYVv4NbuM/8uOcNOpp8uaDa6bX+s6HG6fvG1715R1qjUgmN4MFbp2RNJtER03f//GjDefaNpZKHVCYfJJ9akQziwvRKxn/DoKFLO/w9BAqct0I8FhUhkeMlv/KL4cdtoEu/HVbTRtI3Rxf+8Xzfin1NWQLCPjIMB8Y7x/+mEEz+yT2Mgpw2NHUWqxHPFq1TzbwhaK16hvpo0bhEgUI0=;MaHHUADfKhLk2kLH1FYBYg=="
---

